See all results

Coronavirus (COVID-19) Updates

For the latest COVID-19 information and updates from Qatar Foundation, please visit our Statements page

March 23, 2016

Investment in Biomedical Research and Development Addressed at ARC’16

An informative health panel session that highlightedthe progress that has been made to advance the national cancer and diabetes strategies took place as part of Qatar Foundation Research and Development’s (QF R&D) Annual Research Conference 2016 (ARC’16).
The session, entitled ‘Biomedical and Health Research in Qatar: Transforming Challenges into Competitive Advantages and Economic Opportunities’ dealt with two of the nation’s Research Grand Challenges pillars in the Qatar National Research Strategy (QNRS).

A key topic of discussion during the session was the prevalence of diabetes in Qatar and effective strategies that can be employed to reduce the number of people suffering from the illness.

The session highlighted the major achievements made by the National Center for Cancer Care and Research at Hamad Medical Corporation, which contribute towards advancing Qatar as a regional leader in cancer research and care.

The session closed with two presentations on the progress that has been made on the implementation of the Qatar Genome Project (QGP), which was announced by Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation for Education, Science and Community Development (QF) at the World Innovation Summit on Health (WISH) in 2013. The Project is currently being spearheaded by Qatar Biobank and Sidra Medical and Research Center.

The session and panel discussion brought to light the economic implications that accompany dependency on assistance from the outside world. It highlighted the great investment opportunities and economic returns from investing in research that could yield innovative strategies and technologies for early detection and prevention of diseases such as diabetes and cancer.

For the full story, please click here.